Sign in

CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company

BioRestorative Therapies, Inc.

Sign in to watch
Ticker
BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
301341024
Phone
(631) 760-8100
Business address
40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
Former names
Stem Cell Assurance, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. 4 Open-market buy President, CEO, COB bought 200 shares at an average $2.92 ($584)
  3. 8-K Event Material agreement · Auditor change · Bylaws or fiscal year change · Regulation FD disclosure
  4. 4 Open-market buy VP of Research and Development bought 5,723 shares at an average $3.28 ($18,777)
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. 10-Q Report Quarterly Report
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. 4 Open-market buy 10% owner bought 1,200 shares at an average $3.01 ($3,611)
  9. SC 13G Stake Amended Statement of Ownership
  10. 4 Open-market buy President, CEO, COB bought 700 shares at $2.95 ($2,065)
  11. 4 Open-market buy 10% owner bought 1,900 shares at $3.08 ($5,850)
  12. 4 Open-market buy President, CEO, COB bought 1,100 shares at $3.10 ($3,408)
  13. 424B3 Offering Prospectus
  14. 4 Open-market buy 10% owner bought 700 shares at an average $3.79 ($2,650)
  15. SC 13D/A Stake Beneficial Ownership Report
  16. 4 Open-market buy 10% owner bought 3,200 shares at an average $3.77 ($12,075)
  17. 4 Open-market buy President, CEO, COB bought 600 shares at $3.73 ($2,238)
  18. EFFECT Other Notice of Effectiveness
  19. 4 Open-market buy Chief Financial Officer bought 194 shares at $3.61 ($700)
  20. 4 Open-market buy President, CEO, COB bought 700 shares at $3.68 ($2,578)

Page 11 of 38 · 755 filings